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Abstract. Cell surface tyrosine kinase receptors are
subject to a rapid activation by their ligand, which is
followed by secondary regulatory processes. The IHE2
cell line is a unique model system to study the regula-
tion of EGF binding to EGF receptors after activation
of the EGF receptor kinase. IHE2 cells express both a
chimeric insulin-EGF receptor kinase (IER) and a ki-
nase-deficient EGF receptor (HER K721A) . We have
previously reported that IER is an insulin-responsive
EGF receptor tyrosine kinase that activates one or sev-
eral serine/threonine kinases, which in turn phosphor-
ylate(s) the unoccupied HER K721A . In this article
we show that insulin through IER activation induces a
decrease in 'ZSI-EGF binding to IHE2 cells. Scatchard
analysis indicates that, as for TPA, the effect of insulin
can be accounted for by a loss of the high affinity bind-
HE EGF receptor is a 170-kD transmembrane glyco-
protein. The extracellular region contains the growth
factor binding domain, whereas the intracellular re
gion carries the tyrosine kinase catalytic domain (33, 38) .
These two functions of the EGF receptor, i .e., EGF binding
and tyrosine kinase activity, play cardinal roles in the induc-
tion of the EGF biological effects and are subject to fine reg-
ulatory mechanisms. Receptor tyrosine kinase activity is
positively regulated by EGF binding, which leads to tyrosine
phosphorylation of the receptor (15, 20, 21, 28) and of cellu-
lar substrates (38) . Recent data have indicated that tyrosine
phosphorylation of the carboxy-terminal tail of the EGF re-
ceptor promotes the interaction with signaling molecules
such as phospholipase C-.y and GTP-ase activating protein
(GAP)' (29) . In addition to these positive regulations, both
the binding function and the kinase activity of the EGF re-
ceptor are subject to negative controls, which are mainly
mediated by activation of protein kinase C. Thus, activators
of protein kinase C, such as tetradecanoyl phorbol acetate
(TPA) or PDGF, decrease the intrinsic tyrosine kinase ac-
1. Abbreviations used in thispaper: GAP, GTP-ase activating protein; HER
K721A, human kinase-deficient EGFreceptor; IER, insulin-EGF receptor
chimerae; TPA, tetradecanoyl phorbol acetate.
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ing of EGF to HER K721A. Since this receptor trans-
modulation persists in protein kinase C downregulated
IHE2 cells, it is likely to be due to a mechanism inde-
pendent of protein kinase C activation. Using an in vi-
tro system of 121I-EGF binding to transmodulated IHE2
membranes, we illustrate that the inhibition of EGF
binding induced by IER activation is related to the
phosphorylation state of HER K721A. Further, studies
with phosphatase 2A, or at a temperature (4°C) where
only IER is functional, strongly suggest that the loss
of high affinity EGF binding is related to the serine/
threonine phosphorylation of HER K721A after IER ac-
tivation. Our results provide evidence for a "homolo-
gous desensitization" of EGF receptor binding after ac-
tivation of the EGF receptor kinase of the IER receptor.
tivity of the EGF receptor (7, 16, 17, 23). The major EGF
receptor site phosphorylated by protein kinase C appears to
be threonine 654 (12, 22) . Studies using site-directed muta-
genesis have shown that phosphorylation of the EGF re-
ceptor at threonine 654 is responsible for protein kinase
C-induced inhibition of the receptor tyrosine kinase (11) .
EGF binding is also altered by activation ofprotein kinase C
(25, 34, 41), but the mechanism by which protein kinase C
induces a loss ofhigh affinity binding sites on EGF receptor
is not entirely elucidated. In fact, replacement of threonine
654 with an alanine residue (9, 11) or a tyrosine residue (27)
does not affect regulation of EGF binding caused by TPA
induced activation of protein kinase C. However, Lin et al.
have reported that the phosphorylation of threonine 654 was
required for the inhibition of EGF binding by TPA (26). A
protein kinase C-independent mechanism has also been im-
plicated in the regulation of the high affinity binding sites of
the EGF receptor. Indeed, PDGF, interleukin l, and tumor
necrosis factor are able to induce a loss of the high affinity
binding sites in cells depleted of protein kinase C after a
long-term TPA treatment (4, 9, 31) . This effect seems to be
linked to the phosphorylation state of the EGF receptor (5,
13) . This heterologous receptor transmodulation provides a
negative regulation of EGF-induced biological effects (33) .
627In a previous report, using a cell line expressing both a
chimeric insulin-EGF tyrosine kinase receptor (IER) and a
kinase-deficient EGF receptor (HER K72 IA), we have shown
that the insulin-activated IER chimeric receptor phosphory-
latesthe HER K721A on tyrosine residues (37). In addition
to this tyrosine transphosphorylation, insulin enhances the
phosphorylation of HER K721A on serine/threonine resi-
dues. This implies that IER activates one or several serine/
threonine kinases, which in turn phosphorylates the unoc-
cupied HER K721A. Those observations demonstrate the
existence ofcross-talk between an unoccupied EGF receptor
and a ligand-activated EGF receptor kinase (37) .
In this work, taking advantage ofthe same receptor model
system, we investigated the regulation of EGF binding to the
HER K721A after insulin-induced stimulation of the IER.
We show that insulin through IER activation induces a de-
crease in EGF binding to IHE2 cells and, as for activation
of protein kinase C, this effect can be accounted for by an
inhibition of the high affinity binding of EGF to cell surface
kinase-deficient EGF receptors. Since this receptor trans-
modulation persisted in IHE2 cells depleted of protein ki-
nase C, it appears to be due to a mechanism independent of
protein kinase C. Studies with phosphatase 2A, or at a tem-
perature where virtually only tyrosine kinases are func-
tional, strongly suggest that this inhibition of high affinity
EGF binding is related to the serine/threonine phosphoryla-
tion of HER K721A after IER activation. In conclusion, we
describe here an original "homologous desensitization" situ-
ation of the EGF receptor binding function after activation
of the EGF receptor kinase of the IER receptor.
Materials andMethods
Mouse EGF "receptor grade" was from Sigma Chemical Co. (St. Louis,
MO) and insulin was from Novo Nordisk Biolabs, Copenhagen, Denmark).
EGF was iodinated as described using the chloramine T methodto aspecific
activity of 150 ACi/Ixg (19). ["P]Orthophosphate was obtained from
Amersham Corp. (Bucks, UK). TPA, Triton X-100, protein A-Sepharose,
and BSA (A7030) were from Sigma Chemical Co. All reagents for SDS-
PAGE were from Bio-Rad Laboratories (Richmond, CA). Antiphosphoty-
rosine antibodies were obtained by immunization ofa sheep with phospho-
tyrosine coupled to bovine IgG and affinity-purified on a phospho-
tyrosine-agarose column (2). mAb108 is a monoclonal antibody directed to
the extracellular domain ofthe human EGF receptor (19). Protein phospha-
lase 2A was a gift of P. Cohen (Department of Biochemistry, Medical
Sciences Institute, University of Dundee, Dundee, UK).
CellLines
Details concerning thegeneration and the culture ofthe IHE2 cell lines have
been previously described (37). In brief, IHE2 cells express both a kinase-
deficient human EGF receptor, HER K721A, and a chimeric receptor IER
composed ofthe extracellular domain ofthe human insulin receptor linked
to the transmembrane and thecytosolic domain ofthe human EGF receptor.
IHE2 cells expressed 2 x 105 IER receptors and 2 x 105 HER K721A
receptors percell. IER cells are mouse NIH3T3 fibroblasts transfected with
the expression plasmid encoding for the chimeric IER receptor (32). The
parental cell line, NIH3T3, expresses 2 x 104 and 1.6 x 104 endogenous
mouse insulin and EGF receptors per cell, respectively.
11.II-EGF Binding to IHE2 Cells
Confluent IHE2 cells in 12-well culture dishes were incubated for 2 h at
37°C in serum-free DME containing 0.2% BSA. After treatment with 0.1
AM insulin or 0.1 AM TPA at 37°C, cells were rapidly cooled on ice. The
binding of subsaturating concentrations of 1251-EGF (0.1 nM) to cell sur-
face receptors was measured by incubation of the cells at 4°C for 3 h in
DME containing 0.2% BSA and 30 mM Hepes (pH 7.4) . For Scatchard
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analyses, the cells were incubated for 3 h at 4°C with increasing concentra-
tions of 1251-EGF (from 10 to 3,000 pM) in the same binding medium.
Nonspecific binding was estimated in incubations containing a 100-fold ex-
cess of unlabeled EGF. Cells were rinsed two times with ice-cold PBS and
solubilized in 0.2 N NaOH. The radioactivity was determined in a gamma-
radiation counter.
Preparation ofIHE2Membranes
After being starved for 2 h in DME containing 0.2% BSA, IHE2 cells in
100-mm culture dishes were treated without and with insulin for 15 min at
37°C. The medium was aspirated and the cells were collected by scraping
either in ice-cold buffer A (50 mM Hepes, pH 7.4, 150 mM NaCl, 1 mM
EGTA, and protease inhibitors [100 U/ml aprotinin and 1 mM PMSF]) or
in ice-cold buffer B, which contains in addition to buffer A, phosphatase
inhibitors (50 mM Hepes, pH 7.4, 150 mM NaCl, 1 mM EGTA, 10 mM
EDTA, 100 mM NaF, 2 mM vanadate, 10 mM Na4P207, and protease in-
hibitors [100 U/ml aprotinin and 1 mM PMSF]). Thereafter, the cells were
homogenized by 15 passages through a 26-gauge needle. The crude mem-
brane preparation was obtained by centrifugation at 15,000 g for 15 min.
Binding of 1251-EGF to IHE2 membranes was measured by incubation of
10-15 jig of membranes in 0.3 ml of 50 mM Hepes, pH 7.4, 150 mM NaCl,
and 0.2% BSA in the presence of 0.1 nM 125I-EGF and unlabeled EGF for
the determination ofthe nonspecific binding. After 3 h ofincubation at4°C,
the membranes were washed two times with PBS and counted.
31P-Labeling ofCells andImmunoblotting with
AntiphosphotyrosineAntibodies
IHE2 cells were labeled with ["P]orthophosphate and HER K721A recep-
tors isolated by inununoprecipitation with mAb108 and SDS-PAGE as de-
scribed (37) . Immunoblotting analysis using anti-phosphotyrosine antibod-
ies was performed as previously described (37).
Protein Phosphatase 2A Treatment
Membranes from IHE2 cells exposed to insulin for 15 min were prepared
in buffer B as described above. After two washes to remove phosphatase
inhibitors, 10-15 wg of membranes were incubated in buffer C (150 mM
NaCI, 5 mM Tris, pH 7.4, 1 mM EGTA, and protease inhibitors) in the
presence of protein phosphatase 2A (10 U/ml final) at 30°C for 20 min.
Control incubations were performed using protein phosphatase 2A inacti-
vated with inhibitors (100 mM NaF and 10 mM Na4P207). At the end of
the treatment, the reaction was stopped by the addition of buffer B and the
binding of 1251-EGF to membranes was measured. In parallel to the bind-
ing studies, membranes from IHE2 cells or 32P-labeled IHE2 cells were
processed and treated with protein phosphatase 2A as described above.
Thereafter, membranes were solubilized for 15 min in buffer B containing
I% Triton X-100 and receptors were obtained by immunoprecipitation with
mAb108 prebound on protein A-Sepharose. Finally, receptors were sub-
jected to SDS-PAGE. Unlabeled receptors were revealed by immunoblot-
ting with antibodies to phosphotyrosine and 1251-protein A, whereas 32p-
labeled receptors were visualized by autoradiography.
Results
Effect ofInsulin and TPA on 121I-EGFBindingto
IHE2 Cells
IHE2 cells expressing both the IER and the HER K721A
were used to study the effect of insulin-activated IER on
1251-EGF binding to HER K721A receptors. Confluent IHE2
cells were incubated at 37°C with insulin for increasing
periods of time, and thereafter the binding of 1251-EGF to
cell surface receptors was measured at 4°C. Fig. 1 A shows
that exposure of IHE2 cells to insulin caused a rapid de-
crease in the binding of 1251-EGF to kinase-deficient EGF
receptors. Maximal inhibition (50% of the specific initial
binding) was observed after 10 min of insulin treatment, and
it remained constant up to 20 min ofinsulin stimulation. The
time course of insulin-induced inhibition of EGF binding to
628Figure 1. (A) Effect of insulin
and TPA on 125I-EGF binding
to IHE2 cells . IHE2 cells in
12-well dishes were incubated
with 0.1 1M insulin (o) or
0.1 AM TPA (o) for the indi-
cated times at 37°C . Specific
'211-EGF binding to cell sur-
face receptorswasdetermined
at 4°C as described in Materi
B
￿
-
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als andMethods . (B) Effect of
insulin on HER K721A num-
ber in IHE2 cells . IHE2 cells
in 12-well dishes were incu-
bated with 0.1 p.M insulin
(hatched bars) for 15 min at
37°C . Thereafter, the binding
of 'III-EGF or antibody to
HER K721A (anti-HER) was
measured at 4°C . Antibody
binding was determined by incubation with 1251-protein A. Data
shown are the mean oftriplicate determinations expressed as a per-
centage of specific binding observed in untreated cells. Similar
results were obtained in three separate experiments . INS, insulin .
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IHE2 cells was compared with that inducedby TPA, which
has been shown to decrease the high affinity EGF binding
(25, 34) . No significant difference betweenthe action ofTPA
and insulin on '211-EGF binding to IHE2 cells was observed
(Fig . 1 A) .
In Fig. 1Bwe examined the number ofcell surface kinase-
deficient EGF receptors after 15 min of exposure to insulin .
The number of receptors was estimated using a monoclonal
antibody against the extracellular domain oftheEGF recep-
tor. We found that insulin did not change the number of im-
munoreactive HER K721A. These data suggest that the in-
sulin-induceddecrease in EGF binding to IHE2 cellscannot
be accounted forby a decrease in the number of cell surface
kinase-deficient EGF receptors .
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Figure 2 . Scatchard analysis of 1251-EGF binding to IHE2 cells af-
ter treatment with insulin and TPA . IHE2 cells in 12-well dishes
were treated with buffer (a), 0.1 IM insulin (o), or 0.1 AM TPA
(o) for 15 min at 37°C. Specific 'z 5I-EGF binding (from 10 to
3,000pM) to cell surface receptorswasdetermined at 4°C . Binding
data were analyzed according to Scatchard . Similar results were
obtained in three separate experiments .
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Figure 3 . Effect of insulin on 125I-EGF binding in protein kinase C
downregulated cells . IHE2 cells in 12-well dishes were exposed to
1 pM TPA for 24 h at 37°C in order to downregulate protein ki-
naseC. Thereafter, control anddownregulatedIHE2 cells were in-
cubated for 15 min without (open bars) or with 0.1 I.M insulin
(hatched bars) or 0.1 /AM TPA (closed bars) . Specific 1211-EGF
bindingwasmeasured at 4°C . The results are presented as themean
fSEMofthree separate experiments, and are expressedas the per-
centage of specific binding observed in untreated cells .
ScatchardAnalysis of 125I-EGFBinding toIHE2 Cells
AfterExposure to Insulin orTPA
Given this unchanged receptor number we examined the
possibility that the effect of insulin was due to a change in
EGF receptor affinity as previously documented for TPA
(25, 34) . Therefore, Scatchard analysis of 1251-EGF binding
to IHE2 cells treated for 15 min with insulin and TPA was
performed (Fig. 2) . In control cellswe obtained acurvilinear
Scatchard plot, which has previously been interpreted to
reflect the presence of two populations of binding sites (19,
24), one in a high affinity state with a dissociation constant
of -0.1 nM (5% of the sites) and a second one with a low
affinity andadissociation constant of-4.9 nM (95% ofthe
sites) . Addition of TPA or insulin led to the virtually com-
plete loss of the high affinity binding ofEGF to the cell sur-
faceHERK721A . Scatchard analysis ofbinding experiments
with higher competing EGF concentrations demonstrated
that control andTPA or insulin-treated cells have an identi-
cal number of low affinity HER K721A receptors (2 x 105
receptors per cell ; data not shown) . Taken together these
data indicate that the effect of insulin on EGF binding in
IHE2 cells was due to a decrease in thehigh affinity binding
to cell surface kinase-deficient EGF receptors .
Effect ofInsulin on
125I-EGFBinding in Protein Kinase C
DownregulatedIHE2 Cells
To further compare the action of insulin and TPA we inves-
tigated the effect of insulin on protein kinase C downregu-
lated IHE2 cells . It haspreviously been documented that in-
cubation of cultured cells with phorbol esters causes the
downregulation of protein kinase C (31) . Confluent IHE2
cells were exposed to 1 p,M TPA for 24 h at 37°C in order
to decrease proteinkinaseC activity (Fig . 3) . In comparison
to control cells, acute TPA addition (15 min) to protein ki-
nase C downregulated IHE2 cells did not lead to an inhibi-
tion of the high affinity 125I-EGF binding to HER K721A.
In contrast, after 15 min of exposure, insulin decreased 'zsI-
EGF binding to a similar extent in both control and TPA-
pretreated cells . Theseresults suggest that themechanism by
629Table L Effect ofInsulinandTPAon EGFBinding
to NIH3T3, IHE2, andIER Cells
% specific 1251-EGF binding
Cell lines
￿
Control
￿
TPA
￿
Insulin
NIH3T3
￿
100 1 1
￿
19 1 3
￿
102 1 3
IHE2
￿
100 1 9
￿
45 1 4
￿
49 f 8
IER
￿
100 1 2
￿
23 f 1
￿
28 f 1
Cells in six-well dishes were incubated with 0.1 PM of insulin or 0.1 /AM of
TPA for 20 min at 37°C. Specific '251-EGF binding to cell surface receptors
was determined at 4°C. The results are presented as the mean t SEM of three
separate experiments, and are expressed as the percentage of specific binding
observed in untreated cells (control). 100% of specific binding (control values)
were 3,443 f 31 cpm, 40,987 t 3,000 cpm, and 2,738 t 39 cpm for NIH3T3,
IHE2, and IER cells, respectively.
which insulin-induced activation of the chimeric IER trans-
modulates EGF binding differs from that of TPA, and is
therefore very likely to be independent of protein kinase C.
Effect ofInsulin and TPA on M7-EGFBinding to
Mld-Type EGFReceptorsin IER Cells
Next we were interested to see whether insulin-induced acti-
vation of the chimeric receptor altered EGF binding to wild-
type EGF receptors. To address this question we have stud-
ied the binding of '251-EGF to wild-type endogenous EGF
receptor in IER cells, which express only the chimeric
receptor. The effect of insulin and TPA on '23I-EGF binding
was examined in parental NIH3T3, IER, and IHE2 cells(Ta-
ble I). In the three cell lines, addition ofTPA resulted in inhi-
bition of '251-EGF binding. Treatment of IER cells by insu-
lin led to a pronounced decrease of 1251-EGF binding (72
of the specific initial binding) to wild-type endogenous EGF
receptor, whereas in nontransfected cells insulin did not
change 1251-EGF binding to EGF receptors. These data in-
dicate that IER activation induced a decrease in EGF binding
not only to the kinase-deficient EGF receptor, but also to the
wild-type EGF receptor.
Role ofReceptor Phosphorylation
on the Insulin-induced Decrease in 12x7-EGF
Bindingto IHE2 Cells
In a previous report we have shown that in IHE2 cellsactiva-
tion of the insulin-EGF chimeric receptor by insulin in-
creases the tyrosine, serine, and threonine phosphorylation
of the kinase-deficient EGF receptor (37). To investigate the
relationship between the phosphorylation state of HER
K721A and its transmodulation by IER, we studied 121I-
EGF binding to membranes from IHE2 cells exposed for 15
min to insulin. IHE2 membranes were prepared in either the
absence or presence of phosphatase inhibitors. When insu-
lin-stimulated IHE2 cells were used to prepare membranes
in a buffer containing phosphatase inhibitors, we observed
a 40% decrease in high affinity 1251-EGF binding to these
membranes (Fig. 4) . In contrast, the effect ofinsulin was not
found when the membrane fractions were isolated in the ab-
sence of phosphatase inhibitors. These data indicate that
transmodulation of the kinase-deficient EGF receptor affin-
ity by insulin-evoked IER activation was dependent on the
receptor phosphorylation state.
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Figure 4. 1251-EGF binding to
membranes from IHE2 cells
exposed to insulin: role of re-
ceptor phosphorylation. Mem-
branes from control (open
bars) or insulin-treated IHE2
cells (hatched bars) were pre-
pared in the absence or pres-
ence ofphosphatase inhibitors
inhibitors
￿
as described in Materials and
Methods. Specific 1251-EGF
binding to IHE2 membranes (10-15 tug/point) was measured at 4°C
for 3 h. The results are presented as the mean t SEM ofthreesepa-
rate experiments and are expressed as the percentage of specific
binding observed in control membranes.
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Phosphatase Without With
InfluenceofTemperatureon the Insulin-induced
Decrease in 12II-EGFBindingto IHE2 Cells
Upon exposure of IHE2 cells to insulin, HER K721A was
phosphorylated on tyrosine, serine, and threonine residues
(37) . Generally speaking, receptor tyrosine kinases have
been found to retain activity at 4°C, while serine/threonine
kinases show no or little activity at this temperature (1, 6) .
Therefore, we performed binding and phosphorylation ex-
periments at 4°C to determine whether tyrosine phosphory-
lation of HER K721A by IER was sufficient for induction of
the decrease in high affinity EGF binding. The effect oftem-
perature on the ability of insulin to decrease '251-EGF bind-
ing to cell surface HER K721A receptors is illustrated in Fig.
5 A . Confluent IHE2 cells were incubated for 2 h either at
37°C or at 4°C, and thereafter exposed for 15 min to insulin.
Finally, 1251-EGF binding to IHE2 cells was measured at
4°C. As described previously, at 37°C insulin decreased
1251-EGF binding to IHE2 cells (50% of inhibition) . How-
ever, at 4°C this decrease caused by insulin was totally ab-
sent. In a parallel experiment we also looked at the phos-
phorylation state of kinase-deficient EGF receptors. After
15 min of insulin stimulation either at 37 or 4°C, IHE2 cells
were solubilized, HER K721A receptors were immunopre-
cipitated with mAb108 and analyzed by SDS-PAGE . Finally,
the tyrosine-phosphorylated proteins were revealed by West-
ern blotting with antibodies to phosphotyrosine. As shown
in Fig. 5 B, activation ofIER receptors by insulin led to tyro-
sine transphosphorylation of HER K721A to a comparable
extent at both 37 and 4°C. In IHE2 cells labeled with
I32p]orthophosphate, treatment by insulin at 37°C increased
phosphorylation of HER K721A, but at 4°C no significant
increase in phosphorylation of this receptor was detected.
Sincewe have previously shown that after 15 min of insulin
stimulation HER K721A retained some phosphorylation on
tyrosine residues with a predominant phosphorylation on
serine and threonine residues (37), these data suggest that at
4°C only the tyrosine kinase of the insulin-EGF chimeric
receptor was active and able to transphosphorylate the
kinase-deficient EGF receptors. As a whole our data indicate
that tyrosine transphosphorylation of the cell surface kinase-
deficient EGF receptors is not sufficient for the induction of
an insulin-mediated decrease in EGF receptor affinity.
1231-EGFBinding to IHE2 Membranes heated with
Protein Phosphatase 2A
To determine whether serine/threonine phosphorylation ofFigure S . Influence oftemperature on the insulin-induced decrease
in 1251-EGF binding to IHE2 cells . (A) IHE2 cells were incubated
at either 37 or 4°C without (open bars) or with 0.1 pM insulin
(hatched bars) for 15 min . Specific 1251-EGF cell surface binding
was measured at4°C . The results are presented asthe mean f SEM
of three separate experiments and are expressed as the percentage
of specific binding observed in untreated cells . (B) Western blot :
IHE2 cells were incubated at either 37 or 4°C without or with 0 .1
,AM insulin for 15 min. The cells were solubilized andHER K721A
was immunoprecipitated and separated bySDS-PAGE . After trans-
fer to an Immobilon Pmembrane, the tyrosine-phosphorylated pro-
teins were revealed by antibodies to phosphotyrosine. For in vivo
labeling, IHE2 cells were incubated with [32p]orthophosphate
(1 mCi/ml) at 37°C for 2 h followed by 30 min at either 37 or 4°C,
and finally for 15 min withoutor with0.1 )AM insulin . After solubil-
ization, the extracted proteins were precipitated with antibody to
HER K721A and analyzed by SDS-PAGE. The gels of the experi-
ment performed at 37 and at 4°C were dried and autoradiographed .
HER K72 1A was correlated with inhibition ofEGF binding,
we studied 1251-EGF binding to transmodulated IHE2 mem-
branes, which were treated with protein phosphatase 2A, a
protein phosphatase considered to be specific for phos-
phoserine and phosphothreonine (8) . Fig . 6 A shows that
when membranes from insulin-stimulated IHE2 cells were
treated with protein phosphatase 2A, the high affinity EGF
binding could be restored . Accordingly, the insulin-induced
phosphorylation of HER K721A in 32P-labeled IHE2 cells
disappeared by treatment ofmembranes with the phospha-
tase (Fig . 6 B) . It has been shown that, in addition to its well-
documented phosphatase activity toward phosphoserine and
phosphothreonine, protein phosphatase2A can exert in vitro
a phosphotyrosine phosphatase activity (8, 18) . To inves-
tigate this possibility we probed the protein phosphatase
2A-treated membranes with antibodies to phosphotyrosine .
The immunoblot shows that under our experimental condi-
tions the protein phosphatase 2A did not remove phosphate
from phosphotyrosine residues (Fig. 6 B) . Hence dephos-
phorylation of phosphoserine and phosphothreonine resi-
dues on HER K721A suffices for the restoration of the high
affinity EGF binding to IHE2 membranes .
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Figure 6. Protein phosphatase 2A treatment of membranes from
IHE2 cells exposed to insulin . (A) Membranes from IHE2 cells ex-
posed without (open bars) or with insulin (hatchedbars)were incu-
bated with protein phosphatase 2A (10 U/ml) at 30°C for 20 min .
Control incubations were performed with protein phosphatase 2A
inactivated by 100 mM NaF and 10 mM Na,P20, . Thereafter, the
binding of 1251-EGF to membranes was measured as described in
the legend to Fig . 4 . (B) Membranes from IHE2 cells or 32P-la-
beled IHE2 cells were treated with protein phosphatase 2A as de-
scribed above. Thereafter, membranes were solubilized and HER
K721A were obtained by immunoprecipitation with mAbl08 and
analyzed by SDS-PAGE . Unlabeled receptors were analyzed by im-
munoblotting with antibodies to phosphotyrosine . The gel with
32plabeled receptors was dried and exposed to film . PP2A, pro-
tein phosphatase 2A .
Discussion
Taking advantage ofIHE2 cells, we have studied the regula-
tion ofEGF binding to EGF receptors after activation of a
serine/threonine kinase linked to the EGF receptor. IHE2
cells express both a chimeric insulin-EGF receptor kinase
(IER) and a kinase-deficient EGF receptor (HER K721A) .
We have shown in a previous report that IER is an insulin-
responsiveEGF receptor tyrosine kinase, which phosphory-
lates the unoccupied HERK721A on tyrosine residues . Fur-
ther, after IER activation HER K721A is phosphorylated on
serine and threonine residues by one or several serine/threo-
nine kinases (37) .
Here we demonstrate that treatment ofIHE2 cells with in-
sulin results in a reduction in EGF binding to HER K721A .
The maximal decrease in EGF binding (50% of initial bind-
ing) is seen after 10 min of insulin treatment and is very simi-
lar to the one observed with TPA . Scatchard analysis indi-
cates that, as for TPA, the effect of insulin on EGF binding
occurs via a reduction in high affinity binding sites ofEGF
to cell surface HER K721A without detectable change in
receptor number. However, in protein kinase C downregu-
lated IHE2 cells, the effect of insulin through IER activation
persists on EGF binding . Hence we would like to conclude
that the transmodulation ofEGF binding caused by insulin
is due to a mechanism distinct from that used by TPA, and
appears thus to be independent of protein kinase C activa-
tion . Further, using IER cells transfected only with the chi-
631meric receptor, we show that insulin decreases the binding
of EGF to wild-type endogenous EGF receptor, indicating
that native EGF receptors are transmodulated upon IER acti-
vation.
Two series of observations led us to investigate the role of
the EGF receptor phosphorylation state in the transmodula-
tion induced by insulin-activated IER: (a) the EGF receptor
phosphorylation on serine and threonine residues appears to
play a role in regulation of receptor functions (33, 35), and
(b) in IHE2 cells we have previously shown that upon 15 min
of insulin stimulation, HER K721A is phosphorylated pre-
dominantly on serine and threonine residues (37). There-
fore, we studied the relationship between the phosphoryla-
tion stateof HER K721A and the loss ofhigh affinity binding
sites using an in vitro system of EGF binding to transmodu-
lated IHE2 membranes. In these experiments, membranes
must be isolated in the presence of phosphatase inhibitors to
preserve the decrease in high affinity binding sites induced
by insulin. This indicates that inhibition of the high affinity
binding sitesofHER K72IA induced by IER activation is de-
pendent on the receptor phosphorylation state. Studies at
4°C illustrate that tyrosine phosphorylation of the cell sur-
face HER K721A by IER is not a sufficient signal to induce
the loss of high affinity binding sites. In fact, at 4°C this
transregulation is not detected, while insulin induces tyro-
sine transphosphorylation ofHER K721A to the same extent
at both 37 and 4°C. In additional experiments we foundthat
dephosphorylation on phosphoserine and phosphothreonine
induced by treatment of transmodulated membranes with
protein phosphatase 2A can completely restore the high
affinity EGF binding. These data indicate that the inhibition
ofEGF binding results from the serine/threonine phosphory-
lation of the EGF receptor.
As a whole, our results strongly suggest that IER activa-
tion stimulates at least one serine/threonine kinase distinct
from protein kinase C, which in turn phosphorylates the un-
occupied HER K721A and consequently alters its affinity for
EGF. Two very recent studies have reported that members
of the mitogen-activated protein kinase family are able to
phosphorylate the EGF receptor on threonine 669 (30, 36).
However, we do not favor the idea that a kinase with such
a specificity could be involved in the phenomena described
in our study, since substitution of threonine 669 by site-
directed mutagenesis has shown that the phosphorylation of
this residue is not required for the modulation of EGF bind-
ing caused by TPA and PDGF (10).
The homologous EGF receptor transmodulation observed
in IHE2 cells is, at least in two respects, similar to the trans-
regulation of EGF receptor induced by heterologous stimuli
such as PDGF, interleukin 1, and tumor necrosis factor (4,
5, 9, 13, 31) . First, both phenomena can occur in protein ki-
nase C-deficient cells, and second, they are related to the
serine/threonine phosphorylation state of the receptor.
Whiteley and Glaser previously reported a possible ho-
mologous regulation of the EGF receptor (39). However, it
appears to be different from the one we observed in our study
for the following reasons. The desensitization described by
these authors is mediated by activation of protein kinase C,
which phosphorylates the EGF receptor at threonine residue
654. Phosphorylation of the EGF receptor on this site is
thought to regulate the receptor kinase activity, but not the
binding parameters of EGF receptors (11, 27) . Additionally,
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in the report of Whiteley and Glaser only 40% of the EGF
receptors are phosphorylated on threonine 654, whereas in
our study we found a complete disappearance of the high
affinity binding sites. Since it has been proposed that EGF
receptor signal transduction occurs predominantly through
this particular population ofhigh affinity EGF receptors (3,
14), we would like to suggest that the homologousdesensiti-
zation we illustrate here plays a pivotal role in attenuation
of EGF signaling.
The mechanism by which EGF receptor phosphorylation
affects its binding parameters could be explained at least by
the two following hypotheses: (a) phosphorylation on ser-
ine/threonine residues ofthe cytoplasmic domain ofthe EGF
receptor could cause a conformational change that is prop-
agated to the extracellular domain and results in the loss of
the high affinity binding sites; and (b) phosphorylation of the
EGF receptor on serine/threonine residues couldinduce as-
sociation of the receptor with a cellular component, as has
previously been described for rhodopsin and arrestin (40) .
This interaction would lead to the disappearance of the high
affinity binding sites. However, we cannot rule out the possi-
bility that the key event in the process leading to the loss of
high affinity binding sites is the phosphorylation by a ser-
ine/threonine kinase of a cellular component, which in turn
interacts with the EGF receptor and decreases the receptor
affinity.
In summary, using a model system consisting ofachimeric
insulin-EGF receptor and a kinase-deficient EGF receptor
we have shown the occurrence of homologous desensitiza-
tion of the EGF receptor binding function. We would like to
suggest that a similar phenomenon also exists among genu-
ine EGF receptors, and provides a newly identified negative
feedback loop of EGF receptor regulation. Desensitization
of EGF receptor binding in concert with protein kinase
C-induced attenuation of the receptor tyrosine kinase could
represent an efficient mechanism for limiting the amplitude
and duration of the EGF mitogenic response.
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